Histopathologic differentiation between localized and systemic scleroderma

American Journal of Dermatopathology

Volumn 20, Issue 3, 1998, Pages 242-245

  Torres, Jorge E ^a   Sánchez, Jorge L ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Histopathologic differentiation; Localized scleroderma; Systemic scleroderma

Indexed keywords

COLLAGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DENSITY; CHILD; DERMIS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SKIN CALCIFICATION; SKIN INFLAMMATION; SYNDROME CREST; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; BIOPSY; CALCINOSIS; CHILD; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0344193114     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199806000-00003     Document Type: Article

References (16)

1. Elder D, Elenitsas R, Jaworsky C, Johnson B Jr. Scleroderma In: Lever's histopathology of the skin. Philadelphia: Lippincott-Raven, 1997:274-8.
2. Fleischmajer R, Perlish JS, Reeves JRT. Cellular infiltrates in scleroderma skin. Arthritis Rheum 1977;20:975-84.
3. O'Leary WA, Montgomery H, Ragsdale WE. Dermatohistology of various types of scleroderma. Arch Dermatol 1957;75:75-87.
4. Subcommittee for Scleroderma. Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
5. Soma Y, Tamakit T, Kikuchi K. Coexistence of morphea and systemic sclerosis. Dermatology 1993;186:103-5.
6. Birdi N, Laxer RM, Thorner P, et al. Localized scleroderma progressing to systemic disease: case report and review of the literature. Arthritis Rheum 1993;36:410-5.
7. Falanga V, Medsger TA. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol 1987;17:648-56.
8. Falanga V, Medsger TA, Reichlin M. Antinuclear and anti-single stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 1987;123:350-3.
9. Fleischmajer R, Damiano V. Nedwich D. The alteration of the subcutaneous tissue in systemic scleroderma. Arch Dermatol 1972; 105:59-66.
10. Fleischmajer R, Nedwich D. Generalized morphea. I. Histology of the dermis and subcutaneous tissue. Arch Dermatol 1972;106:50914.
11. Uitto J, Bauer EA, Eisen AZ. Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts. J Clin Invest 1979;64:921-31.
12. Graves PN, Weiss IK, Perlish JS, Fleischmajer R. Increased procollagen M-RNA levels in scleroderma skin fibroblasts. J Invest Dermatol 1983;80:130-2.
13. Jiménez SA, Feldman G, Bashey RI, et al. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis. Biochem J 1986;237:837-43.
14. Fleischmajer R, Gay S, Meigel WN, Perlish JS. Collagen in the cellular and fibrotic stages of scleroderma. Arthritis Rheum 1978; 21:418-28.
15. Roumm AD, Whiteside TL, Medsger TA, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis. Arthritis Rheum 1984;27:645-53.
16. Majewski, Hunzelmann N, Johnson JP, et al. Expression of intercellular adhesion molecule-1 (ICAM-1 ) in the skin of patients with systemic scleroderma. J Invest Dermatol 1991;97:667-71.